文献速递消化与肝胆胰病理

活检前抗排斥治疗对移植肝组织学特征的影响

Histologic features of allograft livers in patients treated for rejection before biopsy.
PubMed 文献 · Hum Pathol · 2023-02-18

该回顾性研究纳入2018至2021年间53例患者共70次疑似急性细胞性排斥(ACR)的移植肝活检,其中37例活检后临床诊断为ACR,17例活检前接受过激素、抗胸腺细胞球蛋白或其他增强免疫抑制治疗,20例未治疗者为对照。由3名肝脏病理医生盲法独立阅片并按Banff系统分级和计算排斥活动指数(RAI)。结果显示预处理组门管区炎症、内皮炎、RAI及嗜酸性粒细胞均显著低于未预处理组,而胆管炎症/损伤无显著差异。

要点

  • 活检前接受抗排斥治疗可显著减轻门管区炎症和内皮炎,降低RAI。
  • 胆管炎症/损伤在预处理后无显著改善,可能消退较慢。
  • 疑似ACR活检中若见胆管炎症/损伤,应警惕部分治疗后的ACR。

核心结论

  • 活检前抗排斥治疗使门管区炎症和内皮炎变得不显著,而胆管炎症/损伤可能需更长时间消退。
  • 评估疑似ACR时,即使缺乏内皮炎和门管区炎症,胆管炎症/损伤也应提示部分治疗后的ACR。

研究设计与样本

  • 回顾性研究纳入2018至2021年间53例患者共70次疑似ACR的移植肝活检。
  • 37例活检后临床诊断为ACR,其中17例活检前接受过激素、抗胸腺细胞球蛋白或其他增强免疫抑制治疗,20例未预处理者为对照。
  • 每例活检选一张代表性H&E切片,由3名肝脏病理医生盲法独立阅片,按Banff系统分级并计算RAI。

主要发现

  • 预处理组门管区炎症显著少于未预处理组(P < .001)。
  • 预处理组内皮炎显著少于未预处理组(P < .001)。
  • 预处理组RAI显著低于未预处理组(P < .001)。
  • 预处理组嗜酸性粒细胞较未预处理组不显著(P = .048)。
  • 胆管炎症/损伤在两组间无显著差异(P = .32)。

关键数值与推荐

  • 预处理组门管区炎症P < .001,内皮炎P < .001,RAI P < .001,嗜酸性粒细胞P = .048,均显著低于未预处理组。
  • 胆管炎症/损伤P = .32,两组无显著差异。

临床怎么用

  • 解读疑似ACR的移植肝活检时,应询问活检前是否接受过抗排斥治疗。
  • 预处理后门管区炎症和内皮炎可能不显著,但胆管炎症/损伤仍可提示部分治疗后的ACR。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liver biopsy is essential for management in liver transplant patients with clinical features suspicious for acute cellular rejection (ACR). As more patients are transplanted for noninfectious indications, it has become increasingly common for them to receive treatment for presumed ACR before biopsy. The effect of pretreatment on the classic histologic triad of ACR's mixed portal inflammation, endothelialitis, and bile duct damage is not well described. Here we report a retrospective study of 70 liver transplant biopsies performed on 53 patients for suspected ACR between 2018 and 2021. Thirty-seven biopsies had a clinical diagnosis of ACR after biopsy. Pretreatment with steroids, antithymocyte globulin, or other increased immunosuppression was given before biopsy in 17 of 37 cases; 20 not-pretreated cases acted as controls. A representative hematoxylin and eosin-stained slide from each biopsy was reviewed independently in a blinded fashion by 3 hepatic pathologists, graded according to the Banff system, assigned a Rejection Activity Index (RAI), and assessed for other histologic features. We found that pretreated biopsies had significantly less portal inflammation (P < .001), less endothelialitis (P < .001), lower RAI (P < .001), and less prominent eosinophils (P = .048) compared to not-pretreated biopsies. There was no significant difference for the other examined variables, including bile duct inflammation/damage (P = .32). Our findings suggest that portal inflammation and endothelialitis become less prominent with pretreatment, whereas bile duct inflammation/damage may take longer to resolve. When evaluating biopsies for suspected ACR, the finding of bile duct inflammation/damage should raise the possibility of partially treated ACR, even in the absence of endothelialitis and portal inflammation.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Leonard NB, Hale GL, Boylan KE, et al. Histologic features of allograft livers in patients treated for rejection before biopsy. Hum Pathol. 2023. PMID: 36804507. doi:10.1016/j.humpath.2023.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。